Serveur d'exploration sur l'agrobacterium et la transgénèse

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.

Identifieur interne : 000707 ( Main/Exploration ); précédent : 000706; suivant : 000708

Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.

Auteurs : J. Maclean [Afrique du Sud] ; M. Koekemoer [Afrique du Sud] ; A J Olivier [Afrique du Sud] ; D. Stewart [Afrique du Sud] ; I I Hitzeroth [Afrique du Sud] ; T. Rademacher [Allemagne] ; R. Fischer [Allemagne] ; A-L Williamson [Afrique du Sud] ; E P Rybicki [Afrique du Sud]

Source :

RBID : pubmed:17412974

Descripteurs français

English descriptors

Abstract

Virus-like particle-based vaccines for high-risk human papillomaviruses (HPVs) appear to have great promise; however, cell culture-derived vaccines will probably be very expensive. The optimization of expression of different codon-optimized versions of the HPV-16 L1 capsid protein gene in plants has been explored by means of transient expression from a novel suite of Agrobacterium tumefaciens binary expression vectors, which allow targeting of recombinant protein to the cytoplasm, endoplasmic reticulum (ER) or chloroplasts. A gene resynthesized to reflect human codon usage expresses better than the native gene, which expresses better than a plant-optimized gene. Moreover, chloroplast localization allows significantly higher levels of accumulation of L1 protein than does cytoplasmic localization, whilst ER retention was least successful. High levels of L1 (>17% total soluble protein) could be produced via transient expression: the protein assembled into higher-order structures visible by electron microscopy, and a concentrated extract was highly immunogenic in mice after subcutaneous injection and elicited high-titre neutralizing antibodies. Transgenic tobacco plants expressing a human codon-optimized gene linked to a chloroplast-targeting signal expressed L1 at levels up to 11% of the total soluble protein. These are the highest levels of HPV L1 expression reported for plants: these results, and the excellent immunogenicity of the product, significantly improve the prospects of making a conventional HPV vaccine by this means.

DOI: 10.1099/vir.0.82718-0
PubMed: 17412974


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.</title>
<author>
<name sortKey="Maclean, J" sort="Maclean, J" uniqKey="Maclean J" first="J" last="Maclean">J. Maclean</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Molecular and Cell Biology, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Koekemoer, M" sort="Koekemoer, M" uniqKey="Koekemoer M" first="M" last="Koekemoer">M. Koekemoer</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Molecular and Cell Biology, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Olivier, A J" sort="Olivier, A J" uniqKey="Olivier A" first="A J" last="Olivier">A J Olivier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Biovac Institute, Pinelands, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Biovac Institute, Pinelands, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Stewart, D" sort="Stewart, D" uniqKey="Stewart D" first="D" last="Stewart">D. Stewart</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hitzeroth, I I" sort="Hitzeroth, I I" uniqKey="Hitzeroth I" first="I I" last="Hitzeroth">I I Hitzeroth</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rademacher, T" sort="Rademacher, T" uniqKey="Rademacher T" first="T" last="Rademacher">T. Rademacher</name>
<affiliation wicri:level="3">
<nlm:affiliation>Fraunhofer Institute, Aachen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Fraunhofer Institute, Aachen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Aix-la-Chapelle</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fischer, R" sort="Fischer, R" uniqKey="Fischer R" first="R" last="Fischer">R. Fischer</name>
<affiliation wicri:level="3">
<nlm:affiliation>Fraunhofer Institute, Aachen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Fraunhofer Institute, Aachen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Aix-la-Chapelle</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Williamson, A L" sort="Williamson, A L" uniqKey="Williamson A" first="A-L" last="Williamson">A-L Williamson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rybicki, E P" sort="Rybicki, E P" uniqKey="Rybicki E" first="E P" last="Rybicki">E P Rybicki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Molecular and Cell Biology, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17412974</idno>
<idno type="pmid">17412974</idno>
<idno type="doi">10.1099/vir.0.82718-0</idno>
<idno type="wicri:Area/Main/Corpus">000715</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000715</idno>
<idno type="wicri:Area/Main/Curation">000715</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000715</idno>
<idno type="wicri:Area/Main/Exploration">000715</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.</title>
<author>
<name sortKey="Maclean, J" sort="Maclean, J" uniqKey="Maclean J" first="J" last="Maclean">J. Maclean</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Molecular and Cell Biology, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Koekemoer, M" sort="Koekemoer, M" uniqKey="Koekemoer M" first="M" last="Koekemoer">M. Koekemoer</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Molecular and Cell Biology, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Olivier, A J" sort="Olivier, A J" uniqKey="Olivier A" first="A J" last="Olivier">A J Olivier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Biovac Institute, Pinelands, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Biovac Institute, Pinelands, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Stewart, D" sort="Stewart, D" uniqKey="Stewart D" first="D" last="Stewart">D. Stewart</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hitzeroth, I I" sort="Hitzeroth, I I" uniqKey="Hitzeroth I" first="I I" last="Hitzeroth">I I Hitzeroth</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rademacher, T" sort="Rademacher, T" uniqKey="Rademacher T" first="T" last="Rademacher">T. Rademacher</name>
<affiliation wicri:level="3">
<nlm:affiliation>Fraunhofer Institute, Aachen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Fraunhofer Institute, Aachen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Aix-la-Chapelle</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fischer, R" sort="Fischer, R" uniqKey="Fischer R" first="R" last="Fischer">R. Fischer</name>
<affiliation wicri:level="3">
<nlm:affiliation>Fraunhofer Institute, Aachen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Fraunhofer Institute, Aachen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Aix-la-Chapelle</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Williamson, A L" sort="Williamson, A L" uniqKey="Williamson A" first="A-L" last="Williamson">A-L Williamson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rybicki, E P" sort="Rybicki, E P" uniqKey="Rybicki E" first="E P" last="Rybicki">E P Rybicki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Molecular and Cell Biology, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of general virology</title>
<idno type="ISSN">0022-1317</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>DNA Primers (MeSH)</term>
<term>DNA, Viral (genetics)</term>
<term>Gene Expression Regulation, Viral (MeSH)</term>
<term>Genetic Variation (MeSH)</term>
<term>Genetic Vectors (MeSH)</term>
<term>Human papillomavirus 16 (genetics)</term>
<term>Humans (MeSH)</term>
<term>Mice (MeSH)</term>
<term>Plant Leaves (microbiology)</term>
<term>Plant Leaves (virology)</term>
<term>Plants (virology)</term>
<term>Plants, Genetically Modified (MeSH)</term>
<term>Plasmids (MeSH)</term>
<term>Restriction Mapping (MeSH)</term>
<term>Rhizobium (genetics)</term>
<term>Tobacco (microbiology)</term>
<term>Tobacco (virology)</term>
<term>Viral Vaccines (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ADN viral (génétique)</term>
<term>Amorces ADN (MeSH)</term>
<term>Animaux (MeSH)</term>
<term>Cartographie de restriction (MeSH)</term>
<term>Feuilles de plante (microbiologie)</term>
<term>Feuilles de plante (virologie)</term>
<term>Humains (MeSH)</term>
<term>Papillomavirus humain de type 16 (génétique)</term>
<term>Plantes (virologie)</term>
<term>Plasmides (MeSH)</term>
<term>Rhizobium (génétique)</term>
<term>Régulation de l'expression des gènes viraux (MeSH)</term>
<term>Souris (MeSH)</term>
<term>Tabac (microbiologie)</term>
<term>Tabac (virologie)</term>
<term>Vaccins antiviraux (MeSH)</term>
<term>Variation génétique (MeSH)</term>
<term>Vecteurs génétiques (MeSH)</term>
<term>Végétaux génétiquement modifiés (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>DNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>DNA Primers</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Human papillomavirus 16</term>
<term>Rhizobium</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>ADN viral</term>
<term>Papillomavirus humain de type 16</term>
<term>Rhizobium</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Feuilles de plante</term>
<term>Tabac</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Plant Leaves</term>
<term>Tobacco</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Feuilles de plante</term>
<term>Plantes</term>
<term>Tabac</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Plant Leaves</term>
<term>Plants</term>
<term>Tobacco</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Gene Expression Regulation, Viral</term>
<term>Genetic Variation</term>
<term>Genetic Vectors</term>
<term>Humans</term>
<term>Mice</term>
<term>Plants, Genetically Modified</term>
<term>Plasmids</term>
<term>Restriction Mapping</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Amorces ADN</term>
<term>Animaux</term>
<term>Cartographie de restriction</term>
<term>Humains</term>
<term>Plasmides</term>
<term>Régulation de l'expression des gènes viraux</term>
<term>Souris</term>
<term>Vaccins antiviraux</term>
<term>Variation génétique</term>
<term>Vecteurs génétiques</term>
<term>Végétaux génétiquement modifiés</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Virus-like particle-based vaccines for high-risk human papillomaviruses (HPVs) appear to have great promise; however, cell culture-derived vaccines will probably be very expensive. The optimization of expression of different codon-optimized versions of the HPV-16 L1 capsid protein gene in plants has been explored by means of transient expression from a novel suite of Agrobacterium tumefaciens binary expression vectors, which allow targeting of recombinant protein to the cytoplasm, endoplasmic reticulum (ER) or chloroplasts. A gene resynthesized to reflect human codon usage expresses better than the native gene, which expresses better than a plant-optimized gene. Moreover, chloroplast localization allows significantly higher levels of accumulation of L1 protein than does cytoplasmic localization, whilst ER retention was least successful. High levels of L1 (>17% total soluble protein) could be produced via transient expression: the protein assembled into higher-order structures visible by electron microscopy, and a concentrated extract was highly immunogenic in mice after subcutaneous injection and elicited high-titre neutralizing antibodies. Transgenic tobacco plants expressing a human codon-optimized gene linked to a chloroplast-targeting signal expressed L1 at levels up to 11% of the total soluble protein. These are the highest levels of HPV L1 expression reported for plants: these results, and the excellent immunogenicity of the product, significantly improve the prospects of making a conventional HPV vaccine by this means.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">17412974</PMID>
<DateCompleted>
<Year>2007</Year>
<Month>07</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>10</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-1317</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>88</Volume>
<Issue>Pt 5</Issue>
<PubDate>
<Year>2007</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of general virology</Title>
<ISOAbbreviation>J Gen Virol</ISOAbbreviation>
</Journal>
<ArticleTitle>Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.</ArticleTitle>
<Pagination>
<MedlinePgn>1460-1469</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1099/vir.0.82718-0</ELocationID>
<Abstract>
<AbstractText>Virus-like particle-based vaccines for high-risk human papillomaviruses (HPVs) appear to have great promise; however, cell culture-derived vaccines will probably be very expensive. The optimization of expression of different codon-optimized versions of the HPV-16 L1 capsid protein gene in plants has been explored by means of transient expression from a novel suite of Agrobacterium tumefaciens binary expression vectors, which allow targeting of recombinant protein to the cytoplasm, endoplasmic reticulum (ER) or chloroplasts. A gene resynthesized to reflect human codon usage expresses better than the native gene, which expresses better than a plant-optimized gene. Moreover, chloroplast localization allows significantly higher levels of accumulation of L1 protein than does cytoplasmic localization, whilst ER retention was least successful. High levels of L1 (>17% total soluble protein) could be produced via transient expression: the protein assembled into higher-order structures visible by electron microscopy, and a concentrated extract was highly immunogenic in mice after subcutaneous injection and elicited high-titre neutralizing antibodies. Transgenic tobacco plants expressing a human codon-optimized gene linked to a chloroplast-targeting signal expressed L1 at levels up to 11% of the total soluble protein. These are the highest levels of HPV L1 expression reported for plants: these results, and the excellent immunogenicity of the product, significantly improve the prospects of making a conventional HPV vaccine by this means.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Maclean</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koekemoer</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olivier</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Biovac Institute, Pinelands, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stewart</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hitzeroth</LastName>
<ForeName>I I</ForeName>
<Initials>II</Initials>
<AffiliationInfo>
<Affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rademacher</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Fraunhofer Institute, Aachen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fischer</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Fraunhofer Institute, Aachen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Williamson</LastName>
<ForeName>A-L</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rybicki</LastName>
<ForeName>E P</ForeName>
<Initials>EP</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Gen Virol</MedlineTA>
<NlmUniqueID>0077340</NlmUniqueID>
<ISSNLinking>0022-1317</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015967" MajorTopicYN="Y">Gene Expression Regulation, Viral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052162" MajorTopicYN="N">Human papillomavirus 16</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018515" MajorTopicYN="N">Plant Leaves</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010944" MajorTopicYN="N">Plants</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D030821" MajorTopicYN="N">Plants, Genetically Modified</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015183" MajorTopicYN="N">Restriction Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012231" MajorTopicYN="N">Rhizobium</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014026" MajorTopicYN="N">Tobacco</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>7</Month>
<Day>25</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2007</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17412974</ArticleId>
<ArticleId IdType="doi">10.1099/vir.0.82718-0</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Afrique du Sud</li>
<li>Allemagne</li>
</country>
<region>
<li>District de Cologne</li>
<li>Rhénanie-du-Nord-Westphalie</li>
</region>
<settlement>
<li>Aix-la-Chapelle</li>
</settlement>
</list>
<tree>
<country name="Afrique du Sud">
<noRegion>
<name sortKey="Maclean, J" sort="Maclean, J" uniqKey="Maclean J" first="J" last="Maclean">J. Maclean</name>
</noRegion>
<name sortKey="Hitzeroth, I I" sort="Hitzeroth, I I" uniqKey="Hitzeroth I" first="I I" last="Hitzeroth">I I Hitzeroth</name>
<name sortKey="Koekemoer, M" sort="Koekemoer, M" uniqKey="Koekemoer M" first="M" last="Koekemoer">M. Koekemoer</name>
<name sortKey="Maclean, J" sort="Maclean, J" uniqKey="Maclean J" first="J" last="Maclean">J. Maclean</name>
<name sortKey="Olivier, A J" sort="Olivier, A J" uniqKey="Olivier A" first="A J" last="Olivier">A J Olivier</name>
<name sortKey="Rybicki, E P" sort="Rybicki, E P" uniqKey="Rybicki E" first="E P" last="Rybicki">E P Rybicki</name>
<name sortKey="Rybicki, E P" sort="Rybicki, E P" uniqKey="Rybicki E" first="E P" last="Rybicki">E P Rybicki</name>
<name sortKey="Stewart, D" sort="Stewart, D" uniqKey="Stewart D" first="D" last="Stewart">D. Stewart</name>
<name sortKey="Williamson, A L" sort="Williamson, A L" uniqKey="Williamson A" first="A-L" last="Williamson">A-L Williamson</name>
</country>
<country name="Allemagne">
<region name="Rhénanie-du-Nord-Westphalie">
<name sortKey="Rademacher, T" sort="Rademacher, T" uniqKey="Rademacher T" first="T" last="Rademacher">T. Rademacher</name>
</region>
<name sortKey="Fischer, R" sort="Fischer, R" uniqKey="Fischer R" first="R" last="Fischer">R. Fischer</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/AgrobacTransV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000707 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000707 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    AgrobacTransV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:17412974
   |texte=   Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:17412974" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AgrobacTransV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Nov 20 15:45:55 2020. Site generation: Wed Mar 6 15:24:41 2024